CLT-020

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameCLT-020
Drug Alias NameCLT-020
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionLow-density lipoprotein receptor-related protein 6 inhibitors
TargetsLow-density lipoprotein receptor-related protein 6
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCharlesson
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCharlesson
Active IndicationsN/A
Inactive IndicationsMacular Degeneration

Other Information

ATC CodeN/A
Related LinksN/A